Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Databases for RNA Editing Collections.
Lo Giudice C, Mansi L, Pesole G, Picardi E. Lo Giudice C, et al. Among authors: mansi l. Methods Mol Biol. 2021;2284:467-480. doi: 10.1007/978-1-0716-1307-8_25. Methods Mol Biol. 2021. PMID: 33835458
Detection of A-to-I RNA Editing in SARS-COV-2.
Picardi E, Mansi L, Pesole G. Picardi E, et al. Among authors: mansi l. Genes (Basel). 2021 Dec 23;13(1):41. doi: 10.3390/genes13010041. Genes (Basel). 2021. PMID: 35052382 Free PMC article.
RNA Editing Detection in HPC Infrastructures.
Lo Giudice C, Mansi L, Flati T, Gioiosa S, Chillemi G, Libro P, Castrignanò T, Pesole G, Picardi E. Lo Giudice C, et al. Among authors: mansi l. Methods Mol Biol. 2021;2284:253-270. doi: 10.1007/978-1-0716-1307-8_14. Methods Mol Biol. 2021. PMID: 33835447
"Good Wine Makes Good Blood": An Integrated Approach to Characterize Autochthonous Apulian Grapevines as Promising Candidates for Healthy Wines.
Sabetta W, Centrone M, D'Agostino M, Difonzo G, Mansi L, Tricarico G, Venerito P, Picardi E, Ceci LR, Tamma G, Caponio F, Montemurro C, Volpicella M. Sabetta W, et al. Among authors: mansi l. Int J Biol Sci. 2022 Apr 11;18(7):2851-2866. doi: 10.7150/ijbs.70287. eCollection 2022. Int J Biol Sci. 2022. PMID: 35541898 Free PMC article.
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Buisseret L, Loirat D, Aftimos P, Maurer C, Punie K, Debien V, Kristanto P, Eiger D, Goncalves A, Ghiringhelli F, Taylor D, Clatot F, Van den Mooter T, Ferrero JM, Bonnefoi H, Canon JL, Duhoux FP, Mansi L, Poncin R, Barthélémy P, Isambert N, Denis Z, Catteau X, Salgado R, Agostinetto E, de Azambuja E, Rothé F, Craciun L, Venet D, Romano E, Stagg J, Paesmans M, Larsimont D, Sotiriou C, Ignatiadis M, Piccart-Gebhart M. Buisseret L, et al. Among authors: mansi l. Nat Commun. 2023 Dec 12;14(1):8223. doi: 10.1038/s41467-023-44071-8. Nat Commun. 2023. PMID: 38086864 Free PMC article. No abstract available.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin A, Gladieff L, Martínez-García J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fariñas-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarcón J, Follana P, Romero I, Lebreton C, Pérez-Fidalgo JA, Yunokawa M, Dahlstrand H, D'Hondt V, Randall LM; ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators. Oaknin A, et al. Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1. Lancet. 2024. PMID: 38048793 Clinical Trial.
246 results